Hospital care remains a central concern, as facilities may not prioritize T1D management when a patient is admitted for another condition. Staff may be unfamiliar with insulin pumps or CGMs. That lack of training can lead to high blood glucose levels, delayed healing, and increased risk of infection.

“If they only cared for us properly while treating us, we’d heal better, faster, and healthier,” she said. She believes the problem is not just practice, but proof. 

Research Gaps in Later-Life Care

She believes lasting change depends on evidence. “Research is essential,” she said. “That is the only way things will change.”

She points to several high-need areas:

• Hospital care for adult T1Ds. There has never been a comprehensive study focused specifically on how hospitals manage insulin-dependent patients during admissions.
• Housing and long-term care access. Some adults report being denied placement or charged additional fees because they require daily insulin management.
• Standardized training for auxiliary caregivers in assisted living and home settings to safely support insulin therapy and glucose monitoring.

Without research, Milo argues, lived experience remains anecdotal. “No data means no validation,” she said. “And that leads to no changes.”

Many studies excluded participants over age 65 due to concerns about comorbidities and polypharmacy. That exclusion, she said, has delayed progress in understanding the unique needs of older adults living with type 1 diabetes.

Meaningful progress over the next decade would include targeted studies in hospital care, housing standards, and caregiver education, along with continued funding for improved technology and therapies.

She acknowledges that many who have lived with it for more than 50 years may not personally benefit from future research findings. “Any changes we start to initiate now will most likely not impact most of us in time,” she said.

For that reason, Milo encourages gaining knowledge, learning self-advocacy skills, and peer support as parallel strategies. One of the most urgent concerns is where people will safely live as they grow older and who will care for them.

Long-Term Care and Housing: a Regulatory Blind Spot

As adults age, many begin to consider assisted living or long-term care. Milo describes the current landscape as the “Wild West.”

Unlike children, who may have protections under 504 plans in schools, there are no consistent federal policies outlining standards of care for older adults in residential settings.

Facilities may:

• Deny residents who use insulin pumps or CGMs
• Charge additional fees for diabetes-related support
• Lack staff trained to recognize and treat hypoglycemia promptly
• Insist that residents rely on their own care providers/family

Transitions into assisted living can introduce new risks, including:

• Delayed treatment of low blood glucose
• Limited support for device management when cognition declines
• Meals that are carbohydrate-heavy and not well balanced
• Difficulty coordinating medications and supplies

She said these gaps create uncertainty and fear for many.

Rethinking Control in Later Life

Another challenge is what she calls “realigning therapies.” For decades, many adults who are living well beyond their predicted “end date” have focused on tight glucose control to reduce long-term complications.

As bodies age, however, insulin sensitivity, hypoglycemia awareness, and glucose response can change. “Tight control can put us at higher risk.”  Physicians talk about “deprescribing,” which most T1Ds react to with anger and fear. The newer term is “realignment” of care, in which changes can be introduced only when an aging T1D can no longer manage well under the rules they have followed for so many years.

She believes clinicians and patients must weigh the trade-off between “good” and “good enough.” Relaxing glucose targets may reduce the risk of severe hypoglycemia (which can result in falls, injuries and loss of consciousness) without significantly increasing long-term risk.

Yet, she said, many long-term survivors resist that shift. “I often mention loosening goals, and I’m met with total resistance. People say, ‘I’m fine.’”

As the body changes, so does the broader medical picture.

Polypharmacy adds complexity. As older adults develop additional health conditions, new medications may interact with insulin in unpredictable ways. Close coordination among primary care physicians and endocrinologists becomes critical.

Advocacy Beyond Awareness

To address these issues, Milo launched T1Dto100.com, a platform focused on older adults navigating later life with T1D.

In less than eight months, she said the T1Dto100 Facebook community has grown to over 3,000 members.

She describes the initiative as a “movement” focused on urgent needs and solutions. “We are having high-level discussions with Breakthrough T1D and the American Diabetes Association (ADA),” she said. And offering free discussions with AARP Senior Planet’s Lunch and Learn series.

Researchers have been receptive and enthusiastic about hearing from the aging community. Service organizations, she noted, often move more slowly.

Through surveys and discussions, the community provides input on research proposals and grants. Milo believes that lived experience should inform study design and policy decisions.

Technology as Protection and Independence

Advances in diabetes technology have changed the trajectory of long-term outcomes. Milo has long been involved in patient-led innovation, including do-it-yourself closed-loop systems known as DIY looping. She recently switched to an implantable CGM and said improved algorithms reduce daily burden. “Let the technology make the corrections,” she said.

She sees technology as protective, allowing older adults to maintain independence longer and reduce the risk of severe highs and lows.

Easier pump interfaces, fewer process steps, and more reliable sensors can support those experiencing changes in vision, dexterity, or cognition.

When formal systems move slowly, she said, patient-driven communities fill the gap. “Our community is often our very best resource.”

Coping with Decades of Management

Living with T1D for decades, Milo said, is simply hard. “It’s unexpectedly variable, costly, time-consuming, and constant.” Managing T1D is an unrelenting task. Blood glucose swings may appear without warning. Curveballs are common.

She emphasizes radical acceptance, mental health support, and finding moments of joy.

She is working with mental health professionals to host virtual events addressing fear of hypoglycemia and other stressors common in later life.

Personally, she looks for small moments and reminders of joy. “A good book, a fun TV show, playing with puppies. Whatever brings joy.”

When management shifts with age, she advises perspective. “The challenges are not personal. Sometimes I cry. Whatever works. A hug always helps.”

Recognizing the Living Legends

If Milo could accelerate one major shift over the next decade, she said it would be recognition. “See us as folks who have been very successful in managing a very difficult disease over a very long period of time. We have strong organizational skills, keeping up with ordering medications, supplies and appointments. We have extreme resilience, bouncing back after bad days and technology failures. And we know how to stay focused.”

Older adults, she said, have navigated with limited tools, evolving technology, and complex health systems.

“We are living legends,” she said. “Surviving proudly despite the predictions.”

As the number of older adults grows, their stories are no longer rare exceptions. They are signals of a demographic shift that demands attention.

Research, training, housing standards, and clinical guidelines must catch up with reality. She believes that by speaking up, organizing, and sharing lived experience, the community can help shape what later life will look like for the next generation.

For now, she and her peers continue into the fourth quarter with eyes open, determined that the end will be defined not by neglect but by progress.